1376354 - Garmin 361-00097-00
Revision Date 10-Jan-2017
Erythema (skin redness). May cause redness and tearing of the eyes. May cause
blindness. Burning. Itching. Rashes. Hives.
Delayed and immediate effects as well as chronic effects from short and long-term exposure
May cause sensitization in susceptible persons. May cause sensitization by skin contact.
Mutagenic Effects
No information available.
The table below indicates whether each agency has listed any ingredient as a carcinogen.
Lithium nickel oxide (LiNiO2)
A1 Group 1 Known X
Lithium Cobalt Oxide
A3 Group 2B X
ACGIH (American Conference of Governmental Industrial Hygienists)
A1 - Known Human Carcinogen
A3 - Animal Carcinogen
IARC (International Agency for Research on Cancer)
Group 1 - Carcinogenic to Humans
Group 2B - Possibly Carcinogenic to Humans
NTP (National Toxicology Program)
Known - Known Carcinogen
OSHA (Occupational Safety and Health Administration of the US Department of Labor)
X - Present
Reproductive toxicity
No information available.
STOT - single exposure
No information available.
STOT - repeated exposure
Causes damage to organs through prolonged or repeated exposure. Based on
classification criteria from the 2012 OSHA Hazard Communication Standard (29 CFR
1910.1200), this product has been determined to cause systemic target organ toxicity from
chronic or repeated exposure. (STOT RE).
Chronic Toxicity
Contains a known or suspected carcinogen. Avoid repeated exposure. Prolonged exposure
may cause chronic effects. May cause adverse effects on the bone marrow and
blood-forming system. May cause adverse liver effects.
Target Organ Effects
Respiratory system. Eyes. Skin. Gastrointestinal tract (GI). Blood. Central Nervous System
(CNS). Central Vascular System (CVS). Kidney. Liver. Lungs. Nasal cavities. Digestive
Aspiration Hazard
No information available.
Numerical measures of toxicity Product Information
The following values are calculated based on chapter 3.1 of the GHS document
ATEmix (oral)
8,411.00 mg/kg
ATEmix (dermal)
5,983.00 mg/kg (ATE)
Page 8 / 12